We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
UPDATE - Canadian Urological Association guideline on androgen deprivation therapy: Adverse events and management strategies.
- Authors
Kokorovic, Andrea; So, Alan I.; Serag, Hosam; French, Christopher; Hamilton, Robert J.; Izard, Jason P.; Nayak, Jasmir G.; Pouliot, Frédéric; Saad, Fred; Shayegan, Bobby; Aprikian, Armen; Rendon, Ricardo A.
- Abstract
The article discusses androgen deprivation therapy (ADT) in thee treatment of castrate-resistant prostate cancer (CRPC). Topics discussed include Evidence-based guidelines on side effects of ADT, ADT-related complication; and cardiometabolic health referred as the effects of ADT on cardiovascular disease (CVD), body composition, and metabolic parameters.
- Subjects
ANDROGEN deprivation therapy; PROSTATE cancer; DYSLIPIDEMIA; ADVERSE health care events; DUAL-energy X-ray absorptiometry; HEALTH services administration; MEDICAL care
- Publication
Canadian Urological Association Journal, 2022, Vol 16, Issue 8, pE416
- ISSN
1911-6470
- Publication type
Article
- DOI
10.5489/cuaj.8054